(lp0
S'Form 8-K AtriCure, Inc. For: Mar 21 StreetInsider.com - Mar 21, 2017 Effective March 21, 2017, the Board of Directors  of AtriCure, Inc.  appointed Regina Groves and B. Kristine Johnson to serve as Directors until the next Annual Meeting of Stockholders.Insider Trading Activity AtriCure Inc.   SVP Sold 20000 shares ... - Market ExclusiveAndrew L. Lux Sells 20000 Shares of AtriCure Inc.  Stock - Chaffey Breeze'
p1
aS'AtriCure Names National Principal Investigator for the CONVERGE IDE Clinical Trial Business Wire  - Mar 14, 2017 MASON, Ohio----AtriCure, Inc. , a leading innovator in surgical treatments for atrial fibrillation  and left atrial appendage management, today announced that it has named Dr.'
p2
aS"Form 3 AtriCure, Inc. For: Mar 21 Filed by: JOHNSON B KRISTINE StreetInsider.com - Mar 21, 2017 Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here. FORM 3, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C."
p3
aS"AtriCure Inc.  Rating Reiterated by Northland Securities Chaffey Breeze - 16 hours ago AtriCure logo AtriCure Inc. 's stock had its buy rating reaffirmed by Northland Securities in a research report issued on Monday.Insider Trading at AtriCure Inc.? - BBNSAtriCure Inc.  Reaches $18.38 After 3.00% Gap Down; Shorts at ... - Wolcott Daily"
p4
aS"BTIG Downgrades AtriCure Inc.  to Neutral StreetInsider.com - Mar 6, 2017 BTIG downgraded AtriCure Inc.  from Buy to Neutral. Analyst Dr. Sea Lavin comments &quot;We followed up with ATRC's management team following the company's earnings report at our Snowbird conference.AtriCure Inc.  Plunges 6.01% on March 06 - Equities.comAtriCure Announces hiring of Senior Vice President of Clinical, Regulatory ... - Yahoo Finance"
p5
aS'Price Alert: AtriCure Inc  Stock Nears Resistance -- Technicals ... CML News - 17 hours ago Price Alert: AtriCure Inc  has now crossed into technical strength -- watch the technical oscillators for momentum gaps.'
p6
aS'AtriCure - Management Needs To Find A Cure For Continued Losses Seeking Alpha - Jan 18, 2017 AtriCure is a great growth story but losses, and the resultant dilution, limit growth for investors. Despite solid growth prospects going forwards, investors are anticipating further dilution as well as profits are not yet in sight.'
p7
aS'Stock Alert: AtriCure Inc Price Volatility Hits A Depressed Level CML News - Mar 19, 2017 Before we cover the full analysis we make a quick alert here that AtriCure Inc  has seen its stock price move at a substantially lowered level.'
p8
aS'AtriCure Enrolls First Patient in Randomized Multi-Center Trial Evaluating ... Business Wire  - Feb 17, 2016 WEST CHESTER, Ohio----AtriCure, Inc. , a leading innovator in treatments for atrial fibrillation  and left atrial appendage management, announced today that the first patient was enrolled and treated at PinnacleHealth&nbsp;...'
p9
aS'AtriCure Inc.  Given Average Recommendation of Buy by Brokerages The Cerbat Gem - Mar 20, 2017 AtriCure logo Shares of AtriCure Inc.  have been assigned an average rating of Buy from the nine ratings firms that are currently covering the stock.AtriCure, Inc.  Target Price At $24 - Markets DailyNorthland Securities Releases a Buy Rating on Atricure - Analyst Ratings'
p10
a.